William Blair Has Weak Outlook for Penumbra FY2025 Earnings

Penumbra, Inc. (NYSE:PEN) – Investment analysts at William Blair dropped their FY2025 earnings per share estimates for Penumbra in a research report issued to clients and investors on Wednesday, April 2nd. William Blair analyst M. Andrew now forecasts that the company will post earnings per share of $3.67 for the year, down from their prior forecast of $3.91. The consensus estimate for Penumbra’s current full-year earnings is $3.67 per share.

Penumbra (NYSE:PEN) last posted its earnings results on Tuesday, February 18th. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.88 by $0.09. The firm had revenue of $315.52 million during the quarter, compared to analysts’ expectations of $311.63 million. Penumbra had a return on equity of 9.74% and a net margin of 1.17%.

A number of other equities research analysts have also recently weighed in on the company. Morgan Stanley boosted their price objective on Penumbra from $240.00 to $260.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 19th. UBS Group upped their price target on shares of Penumbra from $305.00 to $320.00 and gave the company a “buy” rating in a research report on Wednesday, February 19th. JPMorgan Chase & Co. raised their price objective on shares of Penumbra from $230.00 to $285.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 19th. Citigroup upped their target price on shares of Penumbra from $220.00 to $245.00 and gave the company a “neutral” rating in a report on Wednesday, December 11th. Finally, Canaccord Genuity Group boosted their price target on Penumbra from $323.00 to $340.00 and gave the company a “buy” rating in a research report on Wednesday, February 19th. Four equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Penumbra has a consensus rating of “Moderate Buy” and an average price target of $294.47.

Penumbra Stock Down 4.0 %

Penumbra stock opened at $262.37 on Monday. The company has a market capitalization of $10.11 billion, a P/E ratio of 771.66, a PEG ratio of 2.83 and a beta of 0.56. The company has a debt-to-equity ratio of 0.02, a quick ratio of 3.25 and a current ratio of 6.01. Penumbra has a fifty-two week low of $148.00 and a fifty-two week high of $310.00. The stock has a 50-day simple moving average of $274.48 and a 200-day simple moving average of $245.96.

Insiders Place Their Bets

In other Penumbra news, CAO Lambert Shiu sold 501 shares of the company’s stock in a transaction dated Tuesday, March 4th. The shares were sold at an average price of $282.88, for a total value of $141,722.88. Following the transaction, the chief accounting officer now directly owns 32,969 shares in the company, valued at approximately $9,326,270.72. This represents a 1.50 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Adam Elsesser sold 16,565 shares of Penumbra stock in a transaction dated Wednesday, April 2nd. The stock was sold at an average price of $272.24, for a total transaction of $4,509,655.60. Following the sale, the chief executive officer now owns 52,495 shares of the company’s stock, valued at approximately $14,291,238.80. This trade represents a 23.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 111,236 shares of company stock valued at $31,222,390. Corporate insiders own 5.00% of the company’s stock.

Hedge Funds Weigh In On Penumbra

Institutional investors and hedge funds have recently modified their holdings of the company. Versant Capital Management Inc raised its holdings in Penumbra by 893.5% in the 1st quarter. Versant Capital Management Inc now owns 308 shares of the company’s stock valued at $82,000 after acquiring an additional 277 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its position in shares of Penumbra by 74.7% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 3,115 shares of the company’s stock valued at $740,000 after purchasing an additional 1,332 shares during the period. Employees Retirement System of Texas increased its stake in Penumbra by 31.9% in the fourth quarter. Employees Retirement System of Texas now owns 5,273 shares of the company’s stock valued at $1,252,000 after purchasing an additional 1,274 shares during the last quarter. Jefferies Financial Group Inc. purchased a new position in Penumbra during the fourth quarter worth about $760,000. Finally, Polar Asset Management Partners Inc. boosted its stake in Penumbra by 10.5% in the 4th quarter. Polar Asset Management Partners Inc. now owns 122,126 shares of the company’s stock worth $29,002,000 after buying an additional 11,605 shares during the last quarter. Hedge funds and other institutional investors own 88.88% of the company’s stock.

About Penumbra

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.